I'm so excited to share that @endpts.com will be hosting an *in-person* Health Tech happy hour on Nov. 6! Join me and @nyeungs.bsky.social for a drink this fall! More details here: events.endpoints.news/healthtech2025

$13 billion startup Devoted Health grew revenue to $3.3 billion in 2024 and shrank its operating losses, according to my analysis of state insurance filings.

endpts.com/devoted-heal...

Miga Health's co-founders decided to sell instead of building on their success. @lydiapflanzer.bsky.social , head of Endpoints Health Tech newsletter, finds out why that worked for the cardiovascular care start-up.
endpts.com/miga-health-...

I caught up with GoodRx's new CEO Wendy Barnes.

“This platform should be valued considerably higher, given what we delivered historically and the plan that we’ve laid out for ‘25 and beyond. But we’ve got a job to do to school investors to help them to understand that.”

endpts.com/goodrx-ceo-w...

Huge! The @endpts.com Health Tech newsletter just won an award! Thanks @sabew.bsky.social for the recognition of the work @shelbylivingston.bsky.social , Ngai and I are up to! sabew.org/2025/03/2024...

@shelbylivingston.bsky.social gets into Hims' Super Bowl ad debut in today's @endpts.com Health Tech newsletter — check it out: endpts.com/hims-is-maki...

Trump's health tech agenda is starting to emerge.

For today's @endpts.com Health Tech newsletter, I explored the implications the second Trump administration has on the industry, especially as folks like Oracle's Larry Ellison tout the potential for AI in healthcare. lnkd.in/gKXRAtdc

Since the killing of UnitedHealth's top insurance exec and the subsequent outpouring of public frustration with delayed and denied care, a major question has circled the giant: Will it change how it does business?

So far, there’s little sign big reforms are in the works.

endpts.com/unitedhealth...

I got the rundown from Swati Mathai, longtime Elevance Health exec, about her new health plan startup XO Health.

endpts.com/xo-health-la...

FDA reaffirms the tirzepatide shortage is over, @shelbylivingston.bsky.social reports. It's a big blow to those that have been relying on compounded versions endpts.com/in-blow-to-c...

I won't be in SF this year for #JPM25, but I'm so excited about all the sessions @endpts.com planned! Check it out!

Just finding us here? Endpoints News has a starter pack with our journalists so you can follow the team!
go.bsky.app/NzDRUhL

In today's @endpts.com Health Tech newsletter:
- I chatted with VCs about what they're anticipating in 2025, especially with a changing administration
- @shelbylivingston.bsky.social look closer at what's changing for food as medicine

endpts.com/health-tech-...

New: While “prescribing” food is far from the norm, the next administration could change that. Some startups in the food-as-medicine space are already fielding calls from interested investors.

From me and @lydiapflanzer.bsky.social

endpts.com/food-as-medi...

My latest: The killing of UnitedHealthcare's CEO has highlighted the threats increasingly faced by healthcare execs and prompted companies to rethink how they keep their top brass safe.

“This is a huge wake-up call,” the head of exec protection at Allied Universal said.

endpts.com/health-execs...